MetaCap

Emmis Acquisition Corp. Class A Company Profile

NASDAQ: EMISHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.36+0.015 (+0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Emmis Acquisition at a glance

Emmis Acquisition Corp. Class A (NASDAQ: EMIS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Fort Lauderdale, FL. Emmis Acquisition is led by Mr. Peter Joseph Goldstein M.B.A.. The company's shares have traded publicly since 2025.

At a market capitalization of $163.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002075816, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Emmis Acquisition do?

Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on target companies primarily in the service, manufacturing, and distribution sectors, including industrial, business, educational, financial, healthcare, and software services in Southeast Asia and North America. Emmis Acquisition Corp. was incorporated in 2025 and is based in Fort Lauderdale, Florida.

Business description based on the company's public filings.

Company information

Legal name
Emmis Acquisition Corp. Class A
Ticker
NASDAQ: EMIS
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Peter Joseph Goldstein M.B.A.
Headquarters
515 E Las Olas Boulevard, Fort Lauderdale, FL, United States
Phone
201 282 6717
IPO year
2025
Market cap
$163.36M
SEC CIK
0002075816
Latest annual report
10-K · Mar 27, 2026

Companies similar to Emmis Acquisition

EMIS peer companies
CompanyPrice% ChgMarket capCompare
ABEOAbeona Therapeutics Inc.2.42-1.22%$165.31Mvs EMIS
KRROKorro Bio Inc.12.18-0.08%$167.18Mvs EMIS
TRDAEntrada Therapeutics Inc.4.35-6.25%$170.30Mvs EMIS
ORMPOramed Pharmaceuticals Inc.3.57-3.25%$155.24Mvs EMIS
SIGASIGA Technologies Inc.2.40-9.43%$172.45Mvs EMIS
IFRXInflaRx N.V.1.04-4.59%$153.26Mvs EMIS
VOGXVogenx Inc11.87-7.30%$176.33Mvs EMIS
ELDNEledon Pharmaceuticals Inc.1.78-6.32%$150.34Mvs EMIS

Related